Clinical Trials Sponsored by AngioLab, Inc.

Total 35711 results

Ultragenyx Pharmaceutical Inc
Abeona Therapeutics, Inc

Terminated

Gene Transfer Study of ABO-102 in Patients With Middle and Advanced Phases of MPS IIIA Disease

Mucopolysaccharidosis III | Sanfilippo Syndrome | MPS IIIA | Sanfilippo A

United States, Spain, Australia
Radius Pharmaceuticals, Inc.
Benuvia Therapeutics Inc.

Terminated

Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence Seizures

Childhood Absence Epilepsy

United States
RxFunction Inc.
Innovative Design Labs, Inc.

Completed

Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments

Mild Cognitive Impairment | Cognitive Decline | Gait Disorders in Old Age

United States
Merz North America, Inc.
Ulthera, Inc

Completed

Evaluation of the Effectiveness and Safety of the Ulthera® DeepSEE® System for Treating Skin Laxity in the Lower Face and Submentum

Improvement in Skin Laxity of the Lower Face and Submentum

China
Chenland Nutritionals Inc.
KGK Science Inc.

Completed

The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention

Mood

Canada
Telios Pharma, Inc.
Kartos Therapeutics, Inc.

Active, not recruiting

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States, Korea, Republic of, Spain, France, Austria, Australia, Germany, Italy
Chenland Nutritionals Inc.
KGK Science Inc.

Completed

Safety and Efficacy of JointAlive™ on the Knee-joint Function in Adults With Knee Arthritis

Osteo Arthritis Knee

Canada
Applied Biology, Inc.
Jupiter Wellness, Inc.

Withdrawn

Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

Atopic Dermatitis

Brazil
Viatris Pharmaceuticals Japan Inc

Completed

Revatio Special Investigation for Long-term Use in Pediatric Patients

Pulmonary Arterial Hypertension

Japan
EIP Pharma Inc
Voisin Consulting, Inc.

Terminated

Within Subject Crossover Study of Cognitive Effects of Neflamapimod in Early-Stage Huntington Disease

Huntington Disease

United Kingdom
Mesoblast, Inc.
Quintiles, Inc.

Completed

A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)

Grade B aGVHD | Grade C aGVHD | Grade D aGVHD

United States
Mesoblast, Inc.
Quintiles, Inc.

Completed

Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

Grade B Acute Graft Versus Host Disease | Grade C Acute Graft Versus Host Disease | Grade D Acute Graft Versus Host Disease

United States
Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc.

Completed

Mass Balance Study of NV-5138 in Healthy Male Subjects.

Healthy Volunteers

United Kingdom
Mylan Inc.
Mylan GmbH

Completed

Adalimumab PK Bioequivalence Study to EU and US Sourced Humira

Healthy Volunteers

Belgium
Mylan Inc.
Theravance Biopharma

Completed

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD

Chronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)

United States
Mylan Inc.
Theravance Biopharma

Completed

Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment

Hepatic Impairment

United States
Mylan Inc.
Theravance Biopharma

Completed

Thorough QT (TQT) Study of TD-4208 in Healthy Subjects

Cardiac Repolarization in Healthy Subjects

United States
Mylan Inc.
Theravance Biopharma

Completed

TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Mylan GmbH

Completed

Efficacy and Safety Study With MYL-1401H and Neulasta

Breast Neoplasms | Chemotherapy-Induced Febrile Neutropenia

Bulgaria, Georgia, Germany, Hungary, Poland, Ukraine
Mylan Inc.
Mylan GmbH

Completed

Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta

Healthy Volunteers

Netherlands
NSABP Foundation Inc
Puma Biotechnology, Inc.

Completed

Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer

Breast Cancer

United States, Canada, Puerto Rico, Italy, Spain
Merit Medical Systems, Inc.
DFINE Inc.

Terminated

Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) (STARRT)

Metastatic Lesions in Vertebral Bodies

United States
Hill Dermaceuticals, Inc.
Covance; Synteract, Inc.

Terminated

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

United States
Millennium Pharmaceuticals, Inc.
Seagen Inc.

Completed

A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) (ALCANZA)

Mycosis Fungoides | Cutaneous T-Cell Lymphoma | Primary Cutaneous Anaplastic Large Cell Lymphoma

United States, France, Italy, United Kingdom, Spain, Switzerland, Brazil, Austria, Belgium, Germany, Poland, Australia
CAGE Bio Inc.
BioScience Laboratories, Inc.

Completed

Clinical Evaluation of the Residual Antimicrobial Activity

Bacterial Overgrowth

United States
DelMar Pharmaceuticals, Inc.

Withdrawn

A Multi-center Study of VAL-083 in Patients With Recurrent Platinum Resistant Ovarian Cancer (REPROVe)

Ovarian Cancer

United States
Merz North America, Inc.
Ulthera, Inc

Completed

Open-label, Prospective Evaluation of the Ulthera® System for Lifting Submental (Under the Chin) and Neck Tissue in Chinese Patients (ULT-302)

Mild to Moderate Skin Laxity Under the Chin | Mild to Moderate Skin Laxity on Neck

United States
Scynexis, Inc.
ethica Clinical Research Inc.

Completed

Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Dominican Republic
Ulthera, Inc

Completed

Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences

Facial and Neck Skin Laxity

United States
Burt's Bees Inc.
Stephens & Associates, Inc.

Completed

A Clinical Study to Evaluate the Safety and Efficacy of a Baby Cleanser and a Moisturizer

Atopic Dermatitis

United States
Ulthera, Inc

Terminated

Gene Expression Following Ultherapy® Treatment

Skin Laxity

United States
Pfizer
Astellas Pharma Inc; Medivation, Inc.

Withdrawn

Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer (ENDEAR)

Breast Cancer

United States
Asahi Intecc USA Inc
Medpace, Inc.

Completed

The Asahi Intecc PTCA Chronic Total Occlusion Study (CTO-PCI)

Coronary Artery Disease | Coronary Artery Chronic Total Occlusion

United States
Brock Beauty Inc.
KGK Science Inc.

Completed

A Clinical Trial to Evaluate the Effectiveness of Hairfinity on Improving Hair Health and Rate of Growth

Healthy Participants

Canada
Ulthera, Inc

Completed

Ultherapy for the Treatment of Spider Veins on the Legs

Spider Veins | Telangiectasia

United States
Ulthera, Inc

Completed

Ultherapy® for the Treatment of Acne Scars

Acne Scars | Atrophic Acne Scars

United States
Ulthera, Inc

Completed

Ultherapy™ Treatment Following Sculptra® Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Lifting and Tightening of the Face in Subjects With Skin of Darker Color

Facial Skin Laxity

United States
Ulthera, Inc

Completed

Lifting and Tightening of the Face and Neck Following an Increased Density Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Evaluation of the Ulthera System for the Treatment of the Decolletage

Chest Wrinkles

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck

Wrinkles | Skin Laxity

United States
Ulthera, Inc

Terminated

Peri-orbital and Peri-oral Wrinkle Reduction Trial

Peri-oral Wrinkles | Peri-orbital Wrinkles

United States
Ulthera, Inc

Completed

Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne

Facial Acne

United States
Ulthera, Inc

Terminated

Evaluation of the Ulthera® System for Treatment of the Face and Neck

Wrinkles | Skin Laxity | Rhytids

United States
Ulthera, Inc

Terminated

Feasibility Study: Evaluation of the Ulthera® System for Improvement of Surgical Scars.

Surgical Scar

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue

Skin Laxity | Skin Crepiness

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Ulthera® System for Treatment of the Décolleté

Skin Laxity of the décolleté

United States
Ulthera, Inc

Terminated

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

United States

Clinical Trials Sponsored by AngioLab, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations